Here are three things you need to know in the financial markets this morning from investment writer, Tony Cross.
News seems in short supply this morning, but it’s the calm ahead of tomorrow’s flurry of earnings updates we’re expecting from retailers.
#1. Hornby looking towards digital transformation with new appointment?
A note from Hornby LON:HRN advises that a new non-executive director – Henry de Zoete – has agreed to join the firm. This is interesting on two counts, with the company’s shares having rallied hard yesterday and also given the incoming NED’s experience in technology companies. Mr de Zoete’s achievements include establishing Look After My Bills and he is expected to play a key role in the digital transformation of Hornby.
#2. Blue Star Capital play down share price rise
Blue Star Capital LON:BLU was also on our radar last night having seen its shares spar during yesterday’s session. The company has however issued a statement this morning saying it knows of no reason why the price has been marching higher – market speculation that an update was imminent may still look a bit premature but this remains worth watching.
#3. MyHealthChecked announces deal to supply Lloyds Pharmacies
Rounding off, MyHealthChecked LON:MHC has this morning announced a deal to supply Lloyds Pharmacies with pre-departure rapid antigen tests. These accompany the portfolio of PCR test kits already on offer from the pharmacy chain and will allow passengers to take tests at home prior to travel or before returning, with results verified by a professional within two hours. There is however speculation that testing before returning to the UK could be scrapped as soon as this week, which may temper upside potential here.
